UnitedHealthcare Community Plan of Pennsylvania revised its Cardiovascular Disease Risk Tests medical policy for Pennsylvania Medicaid members, effective 2026-12-01. Subfractions or particle size advanced lipoprotein analysis is now listed as unproven and not medically necessary for cardiovascular risk, the list adds noninvasive point-of-care cardiac diagnostic platforms (such as CorVista) for predicting coronary artery disease, pulmonary hypertension, or pulmonary capillary wedge pressure, and CPT 83695 has been removed from the applicable codes.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.
01By 2026-12-01: Billing team should review scheduled and planned cardiovascular risk testing for Pennsylvania Medicaid members, stop scheduling or billing subfractions/particle size advanced lipoprotein analysis and the newly listed point-of-care cardiac diagnostic platforms (e.g., CorVista) for these members, and remove CPT 83695 from charge entry and claim edits for those services.
02Tell providers and front desk staff about the change before it takes effect, and note that services listed as unproven and not medically necessary are expected to be denied for these members, so discuss coverage expectations with patients before performing them.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.